The risk of non-melanoma skin cancer in New Zealand in inflammatory bowel disease patients treated with thiopurines-Reference-Cited by-同舟云学术

The risk of non-melanoma skin cancer in New Zealand in inflammatory bowel disease patients treated with thiopurines

Author:

Bahi Morwan¹,Walmsley Russell S²,Gray Andrew R³,Young David⁴,Hobbs Catherine E¹,Aluzaite Kristina¹,Schultz Michael¹⁵

Affiliation:

1. Department of Medicine, Dunedin School of Medicine; University of Otago; Dunedin New Zealand

2. Department of Gastroenterology, Waitemata District Health Board; North Shore Hospital; Auckland New Zealand

3. Department of Preventive and Social Medicine; University of Otago; Dunedin New Zealand

4. Southern Dermatology Locums Ltd.; Dunedin New Zealand

5. Gastroenterology Unit, Southern District Health Board; Dunedin Hospital; Dunedin New Zealand

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

Reference33 articles.

1. Epidemiology and risk factors for IBD;Ananthakrishnan;Nat. Rev. Gastroenterol. Hepatol.,2015

5. Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease;Prefontaine;Cochrane Database Syst. Rev.,2009

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

5. Therapy in elderly IBD patients;Minerva Gastroenterology;2021-06